Basilea Pharmaceutica AG (OTCMKTS:BPMUF – Get Free Report)’s stock price shot up 13.1% during mid-day trading on Friday . The stock traded as high as $57.70 and last traded at $57.70. 22 shares changed hands during trading, a decline of 78% from the average session volume of 100 shares. The stock had previously closed at $51.00.
Basilea Pharmaceutica Price Performance
The company has a debt-to-equity ratio of 5.70, a quick ratio of 3.27 and a current ratio of 4.10. The firm has a 50-day moving average of $49.42 and a 200-day moving average of $51.70.
Basilea Pharmaceutica Company Profile
Basilea Pharmaceutica AG, a commercial-stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. The company offers Cresemba, an intravenous and antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and the European Union.
Further Reading
- Five stocks we like better than Basilea Pharmaceutica
- How to Invest in Small Cap Stocks
- X: 1 Reason to Bet on U.S. Steel, and 1 Reason to Hold Back
- What Are Dividend Contenders? Investing in Dividend Contenders
- 3 Oversold Stocks Flashing Bullish Reversal Signals
- Are Penny Stocks a Good Fit for Your Portfolio?
- With Novo Nordisk’s CEO Out, Wall Street Wants an American Leader
Receive News & Ratings for Basilea Pharmaceutica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Basilea Pharmaceutica and related companies with MarketBeat.com's FREE daily email newsletter.
